News/ News/ News/ Oncology/ R&D Astellas taps GO’s glycoprotein platform with $783.5m deal Phil Taylor Astellas, glycoprotein, GO Therapeutics, immuno-oncology, Oncology, partnering 0 Comment Astellas has become the latest big pharma company to sink some money into immuno-oncology start-up GO Therapeutics, forging Share X Astellas taps GO’s glycoprotein platform with $783.5m deal https://pharmaphorum.com/news/astellas-taps-gos-glycoprotein-platform-with-783-5m-deal/